The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 16, 2024 for Swaminathan
Indrayani Biotech Ltd. Press Release Dec 17 2024
Filed with BSE · · 5 pages · English
Release
Story so far
Earlier from Indrayani Biotech
Later from Indrayani Biotech
- Indrayani Biotech Ltd. Press Release Jan 02 2025
- Indrayani Biotech Ltd. Press Release Jan 20 2025
- Indrayani Biotech Ltd. Press Release Feb 10 2025
- Indrayani Biotech Ltd. Press Release Feb 14 2025
- Indrayani Biotech Ltd. Press Release Feb 26 2025
Follow Indrayani Biotech into a list and get an email when it puts out news.
Follow Indrayani Biotech